Literature DB >> 5017306

Further studies of porcine malignant hyperthermia.

L W Hall, C M Trim, N Woolf.   

Abstract

A non-lethal procedure for identifying pigs apt to develop malignant hyperthermia is described. Susceptible animals were exposed to a variety of anaesthetic and other agents and it was shown that thiopentone sodium and CT 1341 (Glaxo) afforded a measure of protection against the development of the syndrome. Pretreatment with procaine did not prevent the onset of the condition and the administration of procaine when muscle rigidity was present failed to prevent a fatal outcome. The syndrome was induced in susceptible animals by halothane, chloroform, and a combination of halothane with suxamethonium. The effects of cyclopropane in susceptible pigs could not be predicted, and other tests showed that suxamethonium alone would not induce muscle contracture. Pretreatment with lignocaine failed to prevent induction of the syndrome by halothane.We believe that the porcine syndrome may result from more than one defect and that in one particular type the most effective treatment is immediate cooling coupled with the administration of sodium bicarbonate.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5017306      PMCID: PMC1787967          DOI: 10.1136/bmj.2.5806.145

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  Anaesthetic-induced malignant hyperpyrexia and a method for its prediction.

Authors:  G G Harrison; S J Saunders; J F Biebuyck; R Hickman; D M Dent; V Weaver; J Terblanche
Journal:  Br J Anaesth       Date:  1969-10       Impact factor: 9.166

2.  Malignant hyperthermia.

Authors:  W Kalow
Journal:  Proc R Soc Med       Date:  1970-02

3.  Unusual reaction to suxamethonium chloride.

Authors:  L W Hall; N Woolf; J W Bradley; D W Jolly
Journal:  Br Med J       Date:  1966-11-26
  3 in total
  11 in total

1.  Malignant hyperthermia and althesin.

Authors:  N Honda; K Konno; Y Itohda; M Nishino; S Matsushima; S Haseba; Y Honda; Y Gotoh
Journal:  Can Anaesth Soc J       Date:  1977-07

2.  Amide local anaesthetics and malignant hyperthermia.

Authors:  R T Paasuke; A K Brownell
Journal:  Can Anaesth Soc J       Date:  1986-03

3.  Malignant hyperthermia: an investigation of five patients.

Authors:  B A Britt; W Kalow; A Gordon; J G Humphrey; N B Rewcastle
Journal:  Can Anaesth Soc J       Date:  1973-07

Review 4.  Malignant hyperthermia: molecular defects in membrane permeability.

Authors:  K S Cheah; A M Cheah
Journal:  Experientia       Date:  1985-05-15

Review 5.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

6.  Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.

Authors:  B A Britt; E Scott; W Frodis; M J Clements; L Endrenyi
Journal:  Can Anaesth Soc J       Date:  1984-03

7.  Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars.

Authors:  D C Seeler; W N McDonell; P K Basrur
Journal:  Can J Comp Med       Date:  1983-07

8.  Mitochondrial calcium efflux and porcine stress-susceptibility.

Authors:  K S Cheah; A M Cheah
Journal:  Experientia       Date:  1979-08-15

9.  Erythrocyte osmotic fragility testing and the prediction of canine malignant hyperthermia susceptibility.

Authors:  P H Cribb; E A Olfert; F B Reynolds
Journal:  Can Vet J       Date:  1986-12       Impact factor: 1.008

10.  Procaine in malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1972-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.